Meta-epidemiology of testosterone's risks and benefits-will we ever know the answer?

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)1392
Number of pages1
JournalJAMA Internal Medicine
Volume177
Issue number9
DOIs
Publication statusPublished - 1 Sep 2017

Cite this

@article{03205c7ea0c24713981962cf17f25e43,
title = "Meta-epidemiology of testosterone's risks and benefits-will we ever know the answer?",
author = "Robin Haring",
year = "2017",
month = "9",
day = "1",
doi = "10.1001/jamainternmed.2017.2961",
language = "English",
volume = "177",
pages = "1392",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association (AMA)",
number = "9",

}

Meta-epidemiology of testosterone's risks and benefits-will we ever know the answer? / Haring, Robin.

In: JAMA Internal Medicine, Vol. 177, No. 9, 01.09.2017, p. 1392.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Meta-epidemiology of testosterone's risks and benefits-will we ever know the answer?

AU - Haring, Robin

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85029123425&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2017.2961

DO - 10.1001/jamainternmed.2017.2961

M3 - Comment / Debate

VL - 177

SP - 1392

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 9

ER -